Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP992965priorityCriticalpatent/ECSP992965A/en
Publication of ECSP992965ApublicationCriticalpatent/ECSP992965A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicinal Preparation
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un jarabe antihistaminico es estabilizado contra la degradación del ingrediente activo, mediante la adición de aproximadamente 0,05 a aproximadamente 5mg/mL de un ácido amonipolicarboxilico como ser una sal de ácido etilendiaminatetraacético.An antihistamine syrup is stabilized against degradation of the active ingredient, by adding about 0.05 to about 5mg / mL of an ammonipolycarboxylic acid such as an ethylenediaminetetraacetic acid salt.
Agrochemical compositions comprising a) metconazole or a salt thereof and b) a straight or branched chain aliphatic carboxylic acid, saturated or unsaturated and where the molar ratio of (b) to (a) is greater than 1